GLOBAL INSULIN API MARKET 2019 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2024

Feb 2019 120

Delivery of the Report will take 2-3 working days once order is placed.

Synopsis

Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.
In China and Chinese insulin market, animal insulin, called first generation insulin, has been almost replaced by new type generation insulin. Basing on the trend of China and Chinese insulin industry, this report researches the market of human insulin and insulin analogue in China.
In this report, the statistics of insulin industry is based on Insulin API, the physical features of insulin API is Freeze-dried powder. The weight unite of insulin API weight is Kg in this report.

Scope of the Report:
Insulin API is a relatively concentrated industry in China, The main production are concentrated in Novo Nordisk, Eli Lilly, Sanofi several companies but their products are for their own use. Gan Lee Tonghua Dongbao in recent years to expand production capacity, and they are the main providers of insulin API
The overall domestic policy for the development of insulin API is supported. Local governments have a lot of policies to support the development of the industry. But in recent years environmental protection requirements for the fermentation industry are also getting higher and higher.
The worldwide market for Insulin API is expected to grow at a CAGR of roughly 4.2% over the next five years, will reach 2120 million US$ in 2024, from 1660 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Insulin API in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
- Novo Nordisk
- Sanofi-Aventis
- Eli Lilly
- Tonghua Dongbao
- United Laboratory
- Biocon
- Torrent Pharma
- Amphastar
- Ganlee
- Julphar Diabetes
- Wockhardt

Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
- Regular Human Insulin
- Insulin Analogue

Market Segment by Applications, can be divided into
- Fast-acting
- Premix
- Long-acting

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Insulin API product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Insulin API, with price, sales, revenue and global market share of Insulin API in 2017 and 2018.
Chapter 3, the Insulin API competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Insulin API breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Insulin API market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Insulin API sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

Related reports :

(Feb 19)

Paclitaxel Injection is a kind of anti-cancer injection taking paclitaxel API as raw material. It is mainly used in breast cancer, ovarian c...

(Feb 19)

This report studies the Cyanocobalamin market, Cyanocobalamin is a man-made form of vitamin B12. Vitamin B12 is important for growth, cell r...

(Feb 19)

Simethicone is a mixture of polydimethylsiloxane and hydrated silica gel. It is an orally administered anti-foaming agent used to reduce blo...

(Feb 19)

Laboratory chemical reagents are a series of chemicals used in chemical analysis, synthesis, separation and other fields. Laboratory chemica...

(Feb 19)

Peony is a flowering plant in the genus Paeonia, the only genus in the family Paeoniaceae. Peony varieties with huge, double flowers will be...

(Feb 19)

Octreotide is an octapeptide that mimics natural somatostatin pharmacologically,it is a more potent inhibitor of growth hormone, glucagon, a...

GLOBAL INSULIN API MARKET 2019 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2024


Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Medicine and Pharmacy market as per your needs. Get the best of Medicine and Pharmacy research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy